A work in progress, but a useful construct

被引：29

作者：

Beaser, Richard S.

Levy, Philip

机构：

[1] Joslin Diabet Ctr, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Boston, MA 02115 USA

[3] Univ Arizona, Coll Med, Phoenix, AZ USA

来源：

CIRCULATION | 2007年 / 115卷 / 13期

关键词：

D O I：

10.1161/CIRCULATIONAHA.106.673616

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1812 / 1818

页数：7

共 35 条

[1] Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men [J].

Abate, N ;

Chandalia, M ;

Snell, PG ;

Grundy, SM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2750-2755

[2] Relationship between obesity, insulin resistance, and coronary heart disease risk [J].

Abbasi, F ;

Brown, BW ;

Lamendola, C ;

McLaughlin, T ;

Reaven, GM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :937-943

[3] NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].

Alexander, CM ;

Landsman, PB ;

Teutsch, SM ;

Haffner, SM .

DIABETES, 2003, 52 (05) :1210-1214

[4]

American Association of Clinical Endocrinologists, 2003, ENDOCR PRACT, V9, P240

[5]

[Anonymous], 2006, The IDF Consensus Worldwide Definition of the Metabolic Syndrome

[6] Adipose tissue, inflammation, and cardiovascular disease [J].

Berg, AH ;

Scherer, PE .

CIRCULATION RESEARCH, 2005, 96 (09) :939-949

[7]

Cheta DM, 2006, DIABETES CARE, V29, P176, DOI 10.2337/diacare.29.01.06.dc05-1838

[8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[9] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[10] Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].

Ford, ES ;

Giles, WH ;

Dietz, WH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359

← 1 2 3 4 →